Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

GianMarco Podda

Professore Associato, Direttore ff Medicina Generale 2, Presidio San Paolo, ASST Santi Paolo e Carlo, Milano

Università degli Studi di Torino

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

About

Dr. GianMarco Podda is an Associate Professor and the Acting Director of General Medicine 2 at Presidio San Paolo, ASST Santi Paolo e Carlo in Milano, Italy. He is affiliated with the Università degli Studi di Milano and focuses his research on hematology, particularly in the areas of platelet disorders, immune thrombocytopenia, and anti-platelet therapies. His recent publications include studies on bleeding diathesis, chronic treatment adherence, and the pharmacodynamics of aspirin formulations.

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Marco Cattaneo

Professor

Università degli Studi di Torino

ITALY

View details

Chiara Perucchini

Staff Scientist

Ospedale San Raffaele

ITALY

View details

Francesco Andreata

Tenure Track Assistant Professor

Vita-Salute San Raffaele University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

GianMarco Podda

Research Interests

Make your next move.

Explore related searches

About

Articles (16)

Reflections on left atrial enlargement. Authors’ reply

Platelet-derived serotonin drives age-related lung pathology in SARS-CoV-2 infection

Successful eltrombopag discontinuation in paraneoplastic immune thrombocytopenia: a case report

A case of acquired transient bleeding diathesis associated with acquired platelet storage pool deficiency and defective thromboxane A2 production

Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention

Non-adherence to chronic treatments: A commitment for Internal Medicine specialists

Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count

Prevalence of anti‐platelet factor 4 antibodies in healthy vaccinees with adenoviral vector vaccines—A systematic review and meta‐analysis

Treatment of immune thrombocytopenia (ITP) secondary to malignancy: a systematic review

In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method

MgSO4 anticoagulant prevents pseudothrombocytopenia by preserving the integrity of the platelet GPIIb‐IIIa complex

A case of newly diagnosed immune thrombocytopenia in the COVID-19 era

Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review

An “unmodifiable” risk factor that has been modified

The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians

Direct oral anticoagulants and advanced liver disease: A systematic review and meta‐analysis

Collaborators (3)

Marco Cattaneo

Chiara Perucchini

Francesco Andreata

Make your next move.